Nitroxoline (Asieris Pharmaceuticals)
硝羟喹啉 (亚虹医药)
Report date: 2025/01/10 10:30:33
Base Information
Drug NameNitroxoline (Asieris Pharmaceuticals)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesJohns Hopkins University
China Registration ClassN/A